Ischemia/Reperfusion Injury

Interleukin-6 Can Ameliorate Adverse Effects

Published in Blood Weekly, December 13th, 1999

Oral interleukin-6 (IL-6) can help protect against the deleterious effects of hemorrhage, researchers from the United States report.

F.M. Rollwagen and colleagues, Uniformed Services University of the Health Sciences, Bethesda, Maryland, used a murine model of hemorrhage and resuscitation to measure ischemic consequences of ischemia and reperfusion injury.

Rollwagen et al. presented their study, titled "Orally Administered IL-6 As Protection from Hemorrhage Induced Apoptosis," at the First International Congress on Cytokines/Chemokines in Infectious Diseases held September 8-10, 1999 in Bethesda, Maryland, USA.

Orally administered...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Blood Weekly

Source: Blood Weekly (1999-12-13)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry